Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors

Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors

BackgroundReduced muscle mass has been associated with increased treatment complications in several tumor types. We evaluated the impact of skeletal muscle index (SMI) on prognosis and immune-related adverse events (IrAEs) in a cohort of recurrent/metastatic (R/M) head and neck squamous cell carcino...

Full description

Bibliographic Details
Main Authors: Lorena Arribas, Maria Plana, Miren Taberna, Maria Sospedra, Noelia Vilariño, Marc Oliva, Natalia Pallarés, Ana Regina González Tampán, Luis Miguel Del Rio, Ricard Mesia, Vickie Baracos
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
head and neck (H&N) cancer
body composition
muscle mass
immune checkpoint inhibitors
sarcopenia
immune-related adverse events (irAE)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.699668/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.699668/full

Similar Items